topBtn
News

Vieworks Unveils Digital Slide Scanner VISQUE DPS at USCAP 2025, Marking North American Debut

2025-03-24



BOSTON — Vieworks, a leading provider of medical and industrial imaging solutions, announced it is showcasing its VISQUE DPS (Digital Pathology System) at the USCAP Annual Meeting 2025 in Boston. This marks the first unveiling of the slide scanner in the North American market.
 

The company plans to expand its digital pathology business to major markets, including the United States and Europe, following initial adoption at major hospitals in Korea.
 

Slide scanners are essential devices for digital pathology, enabling cancer diagnostics, clinical research, and tests such as histopathology, liquid-based cytology, and immunopathology. Adoption of digital pathology systems is growing rapidly in developed countries. Vieworks began developing its prototype in 2021, secured domestic regulatory approval in 2023, and launched the enhanced VISQUE DPS earlier this year.
 

The VISQUE DPS is a high-speed digital pathology scanner that reconstructs glass tissue slides into high-resolution whole slide images (WSIs). It supports up to 510 slides at once and generates 83 WSIs (15x15 mm) per hour, making it one of the fastest slide scanners on the market. The system allows semi-permanent digital storage of slides, enabling collaboration and telepathology without relying on traditional microscopes.
 

The device features Vieworks’ proprietary Realtime Extended Focus Mode, which uses its high-resolution camera to capture three images at different focal planes in a single scan. The sharpest areas of each image are combined into a single, highly focused WSI. This extends the depth of focus by more than three times compared with conventional scanners, without increasing scan time or file size. Technology is currently under patent application in Korea.
 

“VISQUE DPS, Korea’s first domestically developed digital pathology system, was successfully introduced at a major hospital in December and has since attracted strong interest from other institutions,” a Vieworks spokesperson said. “We plan to accelerate our expansion into the global digital pathology market, aligning with trends in personalized precision medicine and collaborative care.”
 

Vieworks worked closely with pathologists and specialists at leading Korean hospitals to refine the product, conducting extensive in-house validation to meet clinical needs. The company secured manufacturing approval from the Ministry of Food and Drug Safety in 2023.
 

USCAP (United States and Canadian Academy of Pathology) is an international academic society that leads global pathology research and education, holding annual academic and exhibition events.


  • Listlist
  • Korean
  • English
  • Chinese
English